Chickenpox immunisation disrupted by manufacturing issue at GSK
GlaxoSmithKline has stopped production of chickenpox vaccines, saying it will not restart shipping them until the second quarter, because of quality issues.
The disrupted production has already led to calls for rationing in Germany, a Reuters report said.
Two vaccines, both containing a chickenpox component, have been affected: Priorix-Tetra, a combined vaccine for measles, mumps, rubella and varicella, and Varilrix, a single chickenpox shot.
GlaxoSmithKline spokesperson reported by Reuters.
GSK blames chickenpox vaccine shortage on plant problems (FiercePharma Manufacturing).
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.